Effects of chronic morphine and N6-cyclopentyl-adenosine administration on kainic acid-induced status epilepticus

Epilepsy Research

Volumn 44, Issue 2-3, 2001, Pages 89-96

  Cano Martínez, Agustina ^a,b,c   Villalobos Molina, Rafael ^c   Rocha, Luisa ^b,c  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Receptors; A1 receptors; Adenosine; Kainic acid; Opioid peptides; Status epilepticus

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAINIC ACID; MORPHINE; MU OPIATE RECEPTOR; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; EPILEPTIC STATE; LOCOMOTION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION; SEIZURE; TISSUE DISTRIBUTION; TISSUE LEVEL;

ADENOSINE; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; MALE; MORPHINE; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RECEPTORS, PURINERGIC P1; STATUS EPILEPTICUS; UP-REGULATION;

EID: 2542507503     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(01)00187-5     Document Type: Article

References (48)

1. Albertson T.E., Joy R.M., Stark L.G. Modification of kindled amygdaloid seizures by opiate agonists and antagonists. J. Pharmacol. Exp. Ther. 228:1984;620-627.
2. Angelatao F., Pagonopoulou O., Kostopoulos G. Changes in seizure latency correlate with alterations in A1 adenosine receptor binding during daily repeated pentylenetetrazol-induced convulsions in different mouse brain areas. Neurosci. Lett. 132:1991;203-206.
3. Angelatao F., Pagonopoulou O., Maraziotis T., Oliver A., Villemeure G., Avoli M., Kostopoulos G. Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study. Neurosci. Lett. 163:1993;11-14.
4. 2+ influx. Br. J. Pharmacol. 98:1989;225-235.
5. Berkowitz B.A. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin. Pharmacokinet. 1:1976;219-230.
6. Bohme G.A., Stutzmann J.M., Roques B.P., Blanchard J.C. Effects of selective mu- and delta-opioid peptides on kindled amygdaloid seizures in rats. Neurosci. Lett. 74:1987;227-231.
7. Caldecott-Hazard S., Engel J. Jr. Limbic postictal events: anatomical substrates and opioid receptor involvement. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 11:1987;389-418.
8. Dragunow M., Goddard G.V., Laverty R. Is adenosine an endogenous anticonvulsant? Epilepsia. 26:1985;480-487.
9. Dunwiddie T., Worth T. Sedative and anticonvulsat effects of adenosine analogues in mouse and rat. J. Pharmacol. Exp. Ther. 220:1982;70-76.
10. Engel J. Jr., Sharpless N.S. Long-lasting depletion of dopamine in the rat amygdala induced by kindling stimulation. Brain Res. 136:1977;381-386.
11. Fernández-Guardiola A., Rocha L., Pellicer F., Gutiérrez R., Calvo J.M. Massed amygdaloid kindling in encephale-isole cats: its facilitation by naloxone. Epilepsy Res. 4:1989;55-62.
12. 2 receptors, adenylate cyclase, and the adenosine uptake site. J. Neurochem. 52:1989;641-646.
13. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain-I. J. Neurochem. 13:1966;655-669.
14. Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25:1969;295-330.
15. Herberg L.J., Rose L.C., Mintz M. Effect of an adenosine A1 agonist injected into substantia nigra on kindling of epileptic seizures and convulsion duration. Pharmacol. Biochem. Behav. 44:1993;113-117.
16. Holaday J.W., Hitzemann R.J., Curell J., Tortella F.C., Belenky G.L. Repeated electroconvulsive shock or chronic morphine treatment increases the number of 3H-D-Ala2, D-Leu5-enkephalin binding sites in rat brain membranes. Life Sci. 31:1982;2359-2362.
17. Hong J.S., McGinty J.F., Lee P.H.K., Xie C.W., Mitchell C.L. Relationship between hippocampal opioid peptides and seizures. Prog. Neurobiol. 40:1993;507-528.
18. Lason W., Simpson J.W., McGinty J.F. Mu but not delta opioid receptor stimulation intensifies kainic acid-induced neurotoxicity in rat hippocampus. Neuropeptides. 12:1988;89-94.
19. Lee P.H.K., Obie J., Hong J.S. Opioids induced convulsions and wet dog shakes in rats mediation by hippocampal mu, but not delta or kappa opioid receptors. J. Neurosci. 9:1989;692-697.
20. 6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn-Schmiedebrg's Arch. Pharmacol. 337:1988;687-689.
21. Lothman E., Collins R. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
22. Lowry O.H., Rosenbrough N.A., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265.
23. MacGregor D.G., Graham D.I., Jones P.A., Stone T.W. Protection by adenosine analogue against kainate-induced extrahippocampal neuropathology. Gen. Pharmacol. 31:1998;233-238.
24. Mansour A., Lewis M.E., Khachaturian H., Akil H., Watson S.J. Pharmacological and anatomical evidence of selective mu, delta and kappa opioid receptor binding in rat brain. Brain Res. 399:1986;69-79.
25. Matsuoka Y., Okazaki M., Takata K., Kitamura Y., Ohta S., Sekina Y., Taniguchi T. Endogenous adenosine protects CA1 neurons from kainic acid-induced neuronal cell loss in the rat hippocampus. Eur. J. Neurosci. 11:1999;3617-3625.
26. Munson, P.J., Rodbard, D., 1980. LIGAND: a versatile computerized approach for characterization of ligand binding system. Anal. Biochem. 107-220.
27. Nadler V. Kainic acid a tool for the study of temporal lobe epilepsy. Life Sci. 29:1981;2031-2042.
28. Ochiishi T., Takita M., Ikemoto M., Nakata H., Suzuki S.S. Immunohistochemical analysis on the role of adenosine A1 receptors in epilepsy. Neuroreport. 10:1999;3535-3541.
29. Pagonopoulou O., Angelatou F., Kostopoulos G. Effect of pentylentetrazol-induced seizures on A1 adenosine receptor regional density in the mouse brain: a quantitative autoradiographic study. Neurosci. 56:1993;711-716.
30. Pavan B., Ijzerman A.P. Processing of adenosine receptor agonists in rat and human whole blood. Biochem. Pharmacol. 56:1998;1625-1632.
31. Perry D.C., Grimes L.M. Administration of kainic acid and colchicine alters mu and delta opiate binding in rat hippocampus. Brain Res. 477:1989;100-108.
32. Pinard E., Riche D., Puiroud S., Seylaz J. Theophylline reduces cerebral hyperemia and enhances brain damage induced by seizures. Brain Res. 511:1990;303-309.
33. Ridd M.J., Fosbraey P., Kitchen I. The effect of acute kainic acid treatment on mu-opioid receptors in rat brain. Brain Res. 814:1998;26-33.
34. Rocha L., Ackermann R.F., Nassir Y., Chugani H.T., Engel J. Jr. Characterization of mu opioid receptor binding during amygdala kindling in rats and effects of chronic naloxone pretreatment: an autoradiographic study. Epilepsy Res. 14:1993;195-208.
35. Rocha L., Engel J. Jr., Ackermann R.F. Effects of chronic naloxone pretreatment on amygdaloid kindling in rats. Epilepsy Res. 10:1991;103-110.
36. Rocha L., Ackermann R.F., Engel J. Jr. Effects of chronic morphine pretreatment on amygdaloid kindling development, postictal seizure suppression and benzodiazepine receptor binding in rats. Epilepsy Res. 23:1996;225-233.
37. Rosen J., Berman R. Prolonged postictal depression in amygdala-kindled rats by the adenosine analog, L-phenylisopropyladenosine. Exp. Neurol. 90:1985;549-557.
38. Rothman R.B., McLean S., Bykov V., Lessor R.A., Jacobson A.E., Rice K.C., Holaday J.W. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography. Eur. J. Pharmacol. 142:1987;73-81.
39. Routbort M.J., Bausc S.B., McNamara J.O. Seizures, cell death, and mossy fiber sprouting in kainic acid-treated organotypic hippocampal cultures. Neuroscience. 94:1999;755-765.
40. Schulz R., Wuster M., Herz A. Supersensitivity to opioids following the chronic blockade of endorphin action by naloxone. Naunyn-Schmiedeberg's Arch. Pharmacol. 306:1979;93-96.
41. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
42. Tchekalarova J., Georgiev V. Adenosine-angiotensine II interaction in pentylenetetrazol seizure threshold in mice. J. Physiol. (Paris). 93:1999;191-197.
43. Tortella F.C., Robles L., Mosberg H.I. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. J. Pharmacol. Exp. Ther. 240:1987;571-577.
44. 6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice. Eur. J. Pharmacol. 249:1993;265-270.
45. Whitcomb K., Lupica C.R., Rosen J.B., Berman R.F. Adenosine involvement in postictal events in amygdala-kindled rats. Epilepsy Res. 6:1990;171-179.
46. Yoburn B.C., Paul D., Azimuddin S., Lufty K., Sierra V. Chronic opioid antagonist treatment increases mu and delta receptor mediated spinal opioid analgesia. Brain Res. 485:1989;176-178.
47. Young D., Dragunow M. Neuronal injyury following electrically induced status epilepticus with and without adenosine receptor antagonism. Exp. Neurol. 133:1995;125-137.
48. Zhang G., Franklin P., Murray T. Anticonvulsant effect of N-ethylcaboxamidoadenosine against kainic acid-induced behavioral seizures in the rat prepiriform cortex. Neurosci. Lett. 114:1990;345-350.